Provider stated that she had a patient syncopize on exam table after a dose of gardasil 9 this past year. She said the patient remained alert and recovered. No injury noted.; This spontaneous report was received from Physician via Company Representative referred to a 16-year-old female patient. The patient’s medical history was not reported. The patient’s concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in 2024, the patient started therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, dose number, frequency, scheme, lot #, expiry date, route of administration, and anatomical location were not provided). On an unknown date in 2024, the reporter stated that she had a patient syncopize on exam table after the dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (syncope), and reported that the patient remained alert and recovered on an unknown date; it was also reported that no injury was noted. The reporter did not assess the causal relationship between the syncope and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection. Upon internal review syncope was determined to be medically significant event. Additional information is not expected.